KMID : 0356920110600060393
|
|
Korean Journal of Anesthesiology 2011 Volume.60 No. 6 p.393 ~ p.397
|
|
Comparison of effect-site concentration of remifentanil for tracheal intubation with the lightwand and laryngoscopy during propofol target-controlled infusion
|
|
Kim Jin-Soo
Kim Dae-Hee Min Sang-Kee Kim Kyung-Mi Kim Jong-Yeop
|
|
Abstract
|
|
|
Background: Target-controlled infusion (TCI) of propofol and remifentanil can provide satisfactory intubating conditions without a neuromuscular blocking agent. We compared the effect-site concentration of remifentanil required for intubation with the lightwand and the Macintosh laryngoscope during propofol TCI without a neuromuscular blocking agent in adult patients.
Methods: Forty-nine patients were randomly assigned to the lightwand group (n = 25) or the direct laryngoscope group (n = 24). Anesthesia was induced by propofol TCI with an effect-site concentration of 5.4 ¥ìg/ml. Two minutes after start of propofol TCI, remifentanil was administered at the predetermined effect-site concentration. The effect-site concentration of remifentanil was determined using Dixon¡¯s up-and-down method (0.5 ng/ml as a step size). The first patient in each group was tested at 4.5 ng/ml of remifentanil. Tracheal intubation was performed 2 min after the start of remifentanil TCI. Acceptable intubation was defined as an excellent or good intubating conditions.
Results: Using a modified Dixon¡¯s up and down method, the EC50 ¡¾ SD of remifentanil in the lightwand and laryngoscope groups was 4.75 ¡¾ 0.71 ng/ml and 5.08 ¡¾ 0.52 ng/ml, respectively; there was no statistically significant difference between the groups (P = 0.373).
Conclusions: The effect-site concentration of remifentanil for acceptable intubation with the lightwand and Macintosh laryngoscope in 50% of adults did not differ during propofol TCI without a neuromuscular blocking agent.
|
|
KEYWORD
|
|
Intubation, Lightwand, Propofol, Remifentanil, Target-controlled infusion
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|